Drug archive
Trilostane (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiadrenal
Description
Trilostane (TRYE-loe-stane) is used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland.
This product was withdrawn from the U.S. market in April 1994.